RNST.NYSERenasant CORP

Form 4: RENASANT CFO Sells 12,500 Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


Renasant Corp's EVP and CFO, James C. Mabry IV, sold 12,500 shares of common stock for approximately $472,932 on January 30, 2026, under a Rule 10b5-1 plan.

Worse than expectedThe EVP and CFO sold a significant number of shares (12,500), which can be interpreted by the market as a negative signal, potentially indicating a belief that the stock may be fully valued or that the executive is diversifying their portfolio.

Summary

  • James C. Mabry IV, the Executive Vice President and Chief Financial Officer of Renasant Corp (RNST), reported the sale of company common stock.
  • The transaction involved the disposition of 12,500 shares of common stock.
  • The sale occurred on January 30, 2026, at an average price of $37.8346 per share.
  • The total value of the shares sold is approximately $472,932.50.
  • Following this transaction, Mabry directly beneficially owns 105,337 shares of common stock.
  • The transaction was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a moderately negative signal. While the sale was under a 10b5-1 plan, a key executive selling shares can still be perceived as a lack of strong conviction in significant near-term upside, even if for personal financial planning.

Negatives

  • EVP and CFO James C. Mabry IV sold 12,500 shares of Renasant Corp common stock, which reduces his direct beneficial ownership.
  • Insider selling, even under a 10b5-1 plan, can sometimes be perceived by the market as a signal of reduced confidence or that the stock is fully valued.

Risks

  • Potential investor perception of reduced insider confidence due to the sale of a significant number of shares by a key executive, which could negatively impact stock sentiment.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider selling, especially by a Chief Financial Officer, is often closely scrutinized by the market. While this transaction was executed under a Rule 10b5-1 plan, indicating it was pre-scheduled and not necessarily a reaction to new, negative information, investors often look for patterns in insider activity to gauge management's confidence in the company's future prospects relative to its current valuation.

Stakeholder Impact

  • Shareholders: May interpret the insider sale as a negative signal, potentially impacting investor sentiment and the company's stock price.

Key Dates

DateDescription
01/30/2026Date of earliest transaction (sale of common stock by James C. Mabry IV)
02/02/2026Signature date of the reporting person's attorney-in-fact, Colton Wages

Recommendation

hold

The sale of 12,500 shares by the EVP and CFO, James C. Mabry IV, while notable, is a single insider transaction executed under a Rule 10b5-1 plan. This suggests the sale was pre-arranged and not necessarily a reaction to new, adverse information. Without further context on the executive's overall holdings, compensation structure, or the company's fundamental performance, it is prudent for investors to hold their position and monitor future insider activity and company performance rather than making a drastic move based solely on this filing.

Keywords

Renasant Corp, RNST, Form 4, Insider Trading, Stock Sale, Executive Compensation, James C. Mabry IV, CFO, 10b5-1 Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.